Bioplastics In Medical Devices Market To Reach $5.06 Billion By 2033

Bioplastics In Medical Devices Market Growth & Trends

The global bioplastics in medical devices market size is anticipated to reach USD 5.06 billion by 2033 and is anticipated to expand at a CAGR of 10.3% from 2025 to 2033, according to a new report by Grand View Research, Inc. Bioplastics are rapidly moving from niche R&D into core medical device applications. Manufacturers utilize bioplastics for temporary implants, resorbable sutures, diagnostic housings, and high-volume disposables. The material set spans PLA, PHA, and engineered blends tailored for clinical use. Demand is driven by both clinical need and institutional sustainability goals.

Procurement and regulation are now the primary drivers of adoption. Large health systems and public tenders require lower lifecycle footprints and clearer waste pathways. Device OEMs respond by qualifying medical-grade biopolymers and documenting sterilization and safety data. This creates a predictable commercial pathway for certified materials.

A commercial opportunity exists where the function is temporary, and volumes are high. Resorbable implants, regenerative scaffolds, and disposable diagnostic cassettes offer clear value propositions. Early entrants that solve cost, processing, and regulatory gaps win premium contracts. Strategic partnerships between biopolymer producers and medtech firms accelerate market entry.

Adoption is constrained by technical and economic realities. Sterilization compatibility, controlled degradation rates, and long-term biocompatibility data remain critical clearance hurdles. Feedstock supply and scale keep unit costs above many commodity polymers. Wider uptake depends on validated performance and lower-cost, regulated supply chains.

The market players are focusing on various strategic initiatives such as mergers, acquisitions, and collaborations. For instance, in March 2024, Ambu unveiled its aScope Gastro Large, the world’s first single-use endoscope whose handle is made from bioplastics.

 Request a free sample copy or view report summary: Bioplastics In Medical Devices Market Report

Bioplastics in Medical Devices Market Report Highlights

• Based on material, the PLA segment accounted for the largest share of 45.20% market size in 2024.

• Based on application, the single-use disposables segment accounted for the largest share of 54.12% market size in 2024.

• Asia Pacific dominated the bioplastics in medical devices industry in 2024. Growing investment in localized biopolymer manufacturing across the Asia Pacific is enhancing supply security and reducing costs, thereby accelerating the regional adoption of bioplastics in medical devices.

• China was the leading the market in the Asia Pacific region and captured around 55% of the revenue market share in 2024 in this region.

Bioplastics In Medical Devices Market Segmentation

Grand View Research has segmented the global bioplastics in medical devices market on the basis of material, application, and region:

Bioplastics In Medical Devices Material Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

• PLA

• PHA

• PBS / PBAT

• Other Materials

Bioplastics In Medical Devices Application Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

• Single-use Disposables

• Sterile Packaging & Trays

• Diagnostic Consumables

• Implantable

• Other Applications

Bioplastics In Medical Devices Regional Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

  • UAE

Key Players in the Bioplastics In Medical Devices Market

• NatureWorks LLC

• Danimer Scientific

• BASF SE

• TotalEnergies Corbion

• Novamont S.p.A.

• Mitsubishi Chemical Corporation

• Toray Industries, Inc.

• Biome Bioplastics Limited

• FKuR Kunststoff GmbH

• RWDC Industries